Four Strategies That Medtech Companies Have Used to Monetize Digital Health

Posted by Matt Scheitlin on May 23, 2019

I recently had the privilege of participating in a digital health panel at The MedTech Forum in Paris. The title of the panel was “New Business Models for Digital Health: A Look at Value,” and I was joined by two industry colleagues—Agnes Simon, senior business director, EMEA, at Medtronic, and Lucile Blaise vice president of Western Europe at ResMed—to share our thoughts on business models for digital health in medtech. The conversation was wide-ranging and included tangible strategies for how the industry is currently trying to monetize its digital health innovation. Here are four:


>
Read More

What Medtech Companies Can Learn From Apple's Virtual Clinical Study

Posted by Kate Templeton on March 21, 2019

The American College of Cardiology’s (ACC) Scientific Session and Expo, held March 16-18 in New Orleans, kicked off Saturday morning with the initial results of the much-anticipated Apple Heart Study. For those who keep pace with the fast-moving tech world, I’m sure it felt like an eternity since the study had been announced. But by healthcare standards, the study went quickly and accomplished something unthinkable: It enrolled a breathtaking 419,297 individuals in eight months using a novel, entirely virtual study design.


>
Read More

Generating Value Through Digital and Connected Health Analytics

Posted by Vishal Srivastava on February 13, 2019

"Digitization" has been disrupting several parts of the economy, including the medical devices industry. Beyond the initial hype, we see several programs beginning to show real results and that look promising for improving quality and decreasing healthcare costs. The industry is beginning to look at digital health solutions to drive differentiation as it moves toward focusing on healthcare value and outcomes.


>
Read More

A Medtech Exec, Pharma Exec and Venture Capitalist Walk Onto a Stage and Talk Digital Health

Posted by Pete Masloski on January 10, 2019

Vijesh Unnikrishnan co-wrote this article with Pete Masloski

It’s not often that you get medtech, pharma and venture capital executives to sit on the same panel and participate with enthusiasm and excitement—unless the topic is digital health, where the cross-pollination of ideas and solutions across industry players is becoming more of a norm than an exception. At ZS’s recent Digital and Connected Health Summit, we were fortunate to host a panel of experts who engaged us in a lively discussion: Andy Atwell, executive director of new business development at Omron; Pankaj Dubey, senior director, U.S. commercial, at Abbvie; Divya Varshney, digital health lead at Baxter; and Megan Zweig, director of research at Rock Health. The panelists shared their excitement and optimism, and some examples of how they see life sciences


>
Read More

A ZS Expert Weighs in on the Data-Driven Transformation of Life Sciences

Posted by ZS Editors on December 14, 2018

Digital health is well-positioned to help pharmaceutical and medtech companies create more value for patients. However, the success of digital health solutions is reliant on innovative commercial models—models with a strong focus on data and analytics, and outcomes. 


>
Read More